NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 56 filers reported holding NEUROCRINE BIOSCIENCES INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $19,946,000 | +34.2% | 14,932,000 | +39.7% | 0.02% | +21.1% |
| Q4 2020 | $14,858,000 | -1.3% | 10,691,000 | +18.8% | 0.02% | -17.4% |
| Q2 2020 | $15,054,000 | -45.6% | 9,000,000 | -58.1% | 0.02% | -54.9% |
| Q1 2020 | $27,660,000 | -10.0% | 21,500,000 | +7.5% | 0.05% | +15.9% |
| Q4 2019 | $30,725,000 | +27.7% | 20,000,000 | +14.1% | 0.04% | +10.0% |
| Q3 2019 | $24,052,000 | +4.4% | 17,535,000 | +0.2% | 0.04% | +8.1% |
| Q2 2019 | $23,047,000 | +15.4% | 17,500,000 | +18.6% | 0.04% | +12.1% |
| Q1 2019 | $19,969,000 | +33.6% | 14,750,000 | +18.0% | 0.03% | +17.9% |
| Q4 2018 | $14,952,000 | +25.1% | 12,500,000 | +78.6% | 0.03% | +47.4% |
| Q3 2018 | $11,949,000 | +65.3% | 7,000,000 | +40.0% | 0.02% | +46.2% |
| Q2 2018 | $7,228,000 | – | 5,000,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Myriad Asset Management Ltd. | 17,500,000 | $29,890,000 | 4.31% |
| SSI INVESTMENT MANAGEMENT LLC | 8,987,000 | $15,319,000 | 1.18% |
| CSS LLC/IL | 14,955,000 | $25,561,000 | 1.09% |
| SHENKMAN CAPITAL MANAGEMENT INC | 3,983,000 | $6,799,000 | 0.82% |
| Verition Fund Management LLC | 6,425,000 | $10,968,000 | 0.39% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 9,495,000 | $16,214,000 | 0.33% |
| MACKAY SHIELDS LLC | 21,609,000 | $36,877,000 | 0.28% |
| WOLVERINE ASSET MANAGEMENT LLC | 12,776,000 | $21,819,000 | 0.25% |
| Calamos Advisors LLC | 24,100,000 | $41,405,000 | 0.23% |
| OAKTREE CAPITAL MANAGEMENT LP | 8,895,000 | $15,184,000 | 0.20% |